Background:Preeclampsia
(PE) still ranks as one of obstetrics major problems and is still a serious threat, mainly in underdeveloped countries
where its incidence and mortality rates are higher and is a major cause
of preterm birth and intra-uterine growth restriction. Aim: To evaluate
the role of oxidative stress and dyslipidemia as indicators of pathogenesis and
risks of preeclampsia in pregnant Sudanese women attending Wad-Medani
Obstetrics and Gynecology Teaching Hospital. Material and Method: This was a cross-sectional (case-control) study
carried out in preeclamptic pregnant Sudanese women attending Wad-Medani
Obstetrics and Gynecology Teaching Hospital. A total of 208 pregnant women were enrolled in the study, 111 patients and 97 women with normal pregnancy as
controls; pregnant women suffering from any systemic or
endocrine disorder were excluded. We compared the serum levels of total cholesterol, LDL-cholesterol, HDL-cholesterol,
triglycerides, nitric oxide, and total antioxidant capacity between
preeclamptic and controls. Result and Conclusion: Pregnant women with
increase in BMI have a higher chance of developing PE. Low level of
high-density lipoprotein cholesterol and high level of low-density lipoprotein
cholesterol define that dyslipidemia increases the
risk of PE. Decreased levels of NO and TAC might reflect the
oxidative stress and likely contribute to the pathophysiological mechanisms of
PE.
References
[1]
Whitehouse, A.J., Robinson, M., Newnham, J.P. and Pennell, C.E. (2012) Do Hypertensive Diseases of Pregnancy Disrupt Neurocognitive Development in Offspring? Paediatric and Perinatal Epidemiology, 26, 101-108. https://doi.org/10.1111/j.1365-3016.2011.01257.x
[2]
James, J.L., Whitley, G.S. and Cartwright, J.E. (2010) Pre-Eclampsia: Fitting Together the Placental, Immune and Cardiovascular Pieces. The Journal of Pathology, 221, 363-378. https://doi.org/10.1002/path.2719
[3]
Leeman, L. and Fontaine, P. (2008) Hypertensive Disorders of Pregnancy. American Family Physician, 78, 93-100.
[4]
Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia/Eclampsia. Seminars in Perinatology, 36, 56-59. https://doi.org/10.1053/j.semperi.2011.09.011
[5]
Lin, S., Leonard, D., Co, M.A., Mukhopadhyay, D., Giri, B., Perger, L., Beeram, M.R., Kuehl, T.J. and Uddin, M.N. (2015) Pre-Eclampsia Has an Adverse Impact on Maternal and Fetal Health. Translational Research, 165, 449-463. https://doi.org/10.1016/j.trsl.2014.10.006
[6]
Soto, E., Romero, R., Kusanovic, J.P., Ogge, G., Hussein, Y., Yeo, L., Hassan, S.S., Kim, C.J. and Chaiworapongsa, T. (2012) Late-Onset Preeclampsia Is Associated with an Imbalance of Angiogenic and Anti-Angiogenic Factors in Patients with and without Placental Lesions Consistent with Maternal Underperfusion. The Journal of Maternal-Fetal & Neonatal Medicine, 25, 498-507. https://doi.org/10.3109/14767058.2011.591461
[7]
Ogge, G., Chaiworapongsa, T., Romero, R., Hussein, Y., Kusanovic, J.P., Yeo, L., Kim, C.J. and Hassan, S.S. (2011) Placental Lesions Associated with Maternal Underperfusion Are More Frequent in Early-Onset than in Late-Onset Preeclampsia. Journal of Perinatal Medicine, 39, 641-652.
[8]
Emet, T., Ustuner, I., Guven, S.G., Balik, G., Ural, U.M., Tekin, Y.B., Senturk, S., Sahin, F.K. and Avsar, A.F. (2013) Plasma Lipids and Lipoproteins during Pregnancy and Related Pregnancy Outcomes. Archives of Gynecology and Obstetrics, 288, 49-55. https://doi.org/10.1007/s00404-013-2750-y
[9]
Wild, R., Weedin, E.A. and Wilson, D. (2016) Dyslipidemia in Pregnancy. Endocrinology Metabolism Clinics of North America, 45, 55-63. https://doi.org/10.1016/j.ecl.2015.09.004
[10]
Rajaee, M., Nikuei, P., Nejatizadeh, A., Rahimzadeh, M., Massoodi, M., Abedinejad, M., Moradi, S., Mobarkabady, A., Sedigh, B. and Madani, Z. (2015) Prevalence of Preeclampsia in Hormozgan Province. Hormozgan Medical Journal, 18, No. 6.
[11]
Duhig, K.E. and Shennan, A.H. (2015) Recent Advances in the Diagnosis and Management of Pre-Eclampsia. F1000Prime Reports, 7, 24.
[12]
Leffert, L.R. (2015) What’s New in Obstetric Anesthesia? Focus on Preeclampsia. International Journal of Obstetric Anesthesia, 24, 264-271.
[13]
Adu-Bonsaffoh, K., Antwi, D.A., Obed, S.A. and Gyan, B. (2015) Nitric Oxide Dysregulation in the Pathogenesis of Preeclampsia among Ghanaian Women. Integrated Blood Pressure Control, 2015, 1-6. https://doi.org/10.2147/IBPC.S68454
[14]
Steegers, E.A., von Dadelszen, P., Duvekot, J.J. and Pijnenborg, R. (2010) Pre-Eclampsia. The Lancet, 376, 631-644. https://doi.org/10.1016/S0140-6736(10)60279-6
[15]
Aouache, R., Biquard, L., Vaiman, D. and Miralles, F. (2018) Oxidative Stress in Preeclampsia and Placental Diseases. International Journal of Molecular Sciences, 19, 1496. https://doi.org/10.3390/ijms19051496
[16]
Rodrigo, R., Parra, M., Bosco, C., Fernandez, V., Barja, P., Guajardo, J. and Messina, R. (2005) Pathophysiological Basis for the Prophylaxis of Preeclampsia through Early Supplementation with Antioxidant Vitamins. Pharmacology & Therapeutics, 107, 177-197. https://doi.org/10.1016/j.pharmthera.2005.03.001
[17]
Winkler, K., Wetzka, B., Hoffmann, M.M., Friedrich, I., Kinner, M., Baumstark, M.W., Zahradnik, H.P., Wieland, H. and Marz, W. (2003) Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia. The Journal of Clinical Endocrinology & Metabolism, 88, 1162-1166. https://doi.org/10.1210/jc.2002-021160
[18]
Xiao, H., Arjun, J., Marc, B., Meike, K., Daniel, S., Peter, B. and Christiane, A. (2013) Increased Placental Phospholipid Levels in Pre-Eclamptic Pregnancies. International Journal of Molecular Sciences, 14, 3487-3499.
[19]
Enquobahrie, D.A., Williams, M.A., Butler, C.L., Frederick, I.O., Miller, R.S. and Luthy, D.A. (2004) Maternal Plasma Lipid Concentrations in Early Pregnancy and Risk of Preeclampsia. American Journal of Hypertension, 17, 574-581. https://doi.org/10.1016/j.amjhyper.2004.03.666
[20]
Vani, I., Gayathri, A., Nagamani, T. and Sunieeta, H. (2015) Lipid Profile Parameters in Normal and Preeclampsia Complicating Pregnancies—A Prospective Observational Study. The American Journal of Science and Medical Research, 1, 40-43.
[21]
Enaruna, N.O., Idemudia, J.O. and Aikoriogie, P.I. (2014) Serum Lipid Profile and Uric Acid Levels in Preeclampsia in University of Benin Teaching Hospital. Nigerian Medical Journal, 55, 423-427.
[22]
Singh, U., Yadav, S., Mehrotra, S., Natu, M., Kumari, K. and Yadav, S. (2013) Serum Lipid Profile in Early Pregnancy as a Predictor of Preeclampsia. International Journal of Medical Research and Review, 1, 56.
[23]
Shalini, M. and Rashmi, R. (2011) Study of Serum Lipid Profile and Magnesium in Normal Pregnancy and Preeclampsia. Asian Journal of Biochemistry, 6, 228-239. https://doi.org/10.3923/ajb.2011.228.239
[24]
Pradnya, P. and Mona, T. (2012) Study of Lipid Profile in Preeclampsia. Indian Journal of Basic & Applied Medical Research, 5, 405-409.
[25]
Gohil, J.T., Patel, P.K. and Gupta, P. (2011) Estimation of Lipid Profile in Subjects of Preeclampsia. The Journal of Obstetrics and Gynecology of India, 61, 399-403. https://doi.org/10.1007/s13224-011-0057-0
[26]
Gratacos, E., Casals, E., Gomez, O., Llurba, E., Mercader, I., Cararach, V. and Cabero, L. (2003) Increased Susceptibility to Low Density Lipoprotein Oxidation in Women with a History of Pre-Eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology, 110, 400-404. https://doi.org/10.1046/j.1471-0528.2003.02349.x
[27]
Aleksandrov, N.A., Fraser, W. and Audibert, F. (2008) Diagnosis, Management, and Evaluation of Hypertensive Disorders of Pregnancy. Journal of Obstetrics and Gynaecology Canada, 30, 1000. https://doi.org/10.1016/S1701-2163(16)32992-9
[28]
Seed, P.T., Chappell, L.C., Black, M.A., Poppe, K.K., Hwang, Y.C., Kasabov, N., McCowan, L., Shennan, A.H., Wu, S.H., Poston, L. and North, R.A. (2011) Prediction of Preeclampsia and Delivery of Small for Gestational Age Babies Based on a Combination of Clinical Risk Factors in High-Risk Women. Hypertension in Pregnancy, 30, 58-73. https://doi.org/10.3109/10641955.2010.486460
[29]
Romundstad, P.R., Magnussen, E.B., Smith, G.D. and Vatten, L.J. (2010) Hypertension in Pregnancy and Later Cardiovascular Risk: Common Antecedents? Circulation, 122, 579-584. https://doi.org/10.1161/CIRCULATIONAHA.110.943407
[30]
Ehrenthal, D.B., Jurkovitz, C., Hoffman, M., Jiang, X. and Weintraub, W.S. (2011) Prepregnancy Body Mass Index as an Independent Risk Factor for Pregnancy-Induced Hypertension. Journal of Women’s Health, 20, 67-72. https://doi.org/10.1089/jwh.2010.1970
[31]
Chanchal, S., Nagraj, S., Kaushik, G. and Sharma, R. (2015) Study of Serum Lipid Profile AST and LDH in Pre-Elampsia and Eclampsia. International Journal of Advanced Research, 3, 326-329.
Saben, J., Lindsey, F., Zhong, Y., Thakali, K., Badger, T.M., Andres, A., Gomez-Acevedo, H. and Shankar, K. (2014) Maternal Obesity Is Associated with a Lipotoxic Placental Environment. Placenta, 35, 171-177. https://doi.org/10.1016/j.placenta.2014.01.003
[34]
Staff, A.C., Benton, S.J., von Dadelszen, P., Roberts, J.M., Taylor, R.N., Powers, R.W., Charnock-Jones, D.S. and Redman, C.W. (2013) Redefining Preeclampsia Using Placenta-Derived Biomarkers. Hypertension, 61, 932-942. https://doi.org/10.1161/HYPERTENSIONAHA.111.00250
[35]
Matsubara, K., Higaki, T., Matsubara, Y. and Nawa, A. (2015) Nitric Oxide and Reactive Oxygen Species in the Pathogenesis of Preeclampsia. International Journal of Molecular Sciences, 16, 4600-4614. https://doi.org/10.3390/ijms16034600
[36]
Boger, R.H., Diemert, A., Schwedhelm, E., Luneburg, N., Maas, R. and Hecher, K. (2010) The Role of Nitric Oxide Synthase Inhibition by Asymmetric Dimethylarginine in the Pathophysiology of Preeclampsia. Gynecologic and Obstetric Investigation, 69, 1-13.
[37]
Wander, P. and Jean, S. (2010) The Role of Nitric Oxide in Immune Response Against Trypanosoma Cruzi Infection. The Open Nitric Oxide Journal, 2, 1-6.
[38]
Ehsanipoor, R.M., Fortson, W., Fitzmaurice, L.E., Liao, W.X., Wing, D.A., Chen, D.B. and Chan, K. (2013) Nitric Oxide and Carbon Monoxide Production and Metabolism in Preeclampsia. Reproductive Sciences, 20, 542-548. https://doi.org/10.1177/1933719112459231
[39]
Sharma, D., Singh, A., Trivedi, S.S. and Bhattacharjee, J. (2011) Intergenotypic Variation of Nitric Oxide and Inflammatory Markers in Preeclampsia: A Pilot Study in a North Indian Population. Human Immunology, 72, 436-439. https://doi.org/10.1016/j.humimm.2011.02.007
[40]
Saha, T., Halder, M., Das, A. and Das, S.K. (2013) Role of Nitric Oxide, Angiogenic Growth Factors and Biochemical Analysis in Preeclampsia. Indian Journal of Biochemistry & Biophysics, 50, 462-466.
[41]
Tayal, D., Goswami, B., Patra, S.K., Tripathi, R. and Khaneja, A. (2014) Association of Inflammatory Cytokines, Lipid Peroxidation End Products and Nitric Oxide with the Clinical Severity and Fetal Outcome in Preeclampsia in Indian Women. Indian Journal of Clinical Biochemistry, 29, 139-144. https://doi.org/10.1007/s12291-013-0320-5
[42]
Norris, L.A., Higgins, J.R., Darling, M.R., Walshe, J.J. and Bonnar, J. (1999) Nitric Oxide in the Uteroplacental, Fetoplacental, and Peripheral Circulations in Preeclampsia. Obstetrics & Gynecology, 93, 958-963.
[43]
Moncada, S. and Higgs, E.A. (2006) The Discovery of Nitric Oxide and Its Role in Vascular Biology. British Journal of Pharmacology, 147, S193-S201. https://doi.org/10.1038/sj.bjp.0706458
[44]
Sandrim, V.C., Palei, A.C., Cavalli, R.C., Araujo, F.M., Ramos, E.S., Duarte, G. and Tanus-Santos, J.E. (2008) eNOS Haplotypes Associated with Gestational Hypertension or Preeclampsia. Pharmacogenomics, 9, 1467-1473. https://doi.org/10.2217/14622416.9.10.1467
[45]
Sandrim, V.C., Palei, A.C., Luizon, M.R., Izidoro-Toledo, T.C., Cavalli, R.C. and Tanus-Santos, J.E. (2010) eNOS Haplotypes Affect the Responsiveness to Antihypertensive Therapy in Preeclampsia but Not in Gestational Hypertension. The Pharmacogenomics Journal, 10, 40-45. https://doi.org/10.1038/tpj.2009.38
[46]
Chen, Y., Wang, D., Zhou, M., Chen, X. and Chen, J. (2014) Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Preeclampsia in a Han Chinese Population. Gynecologic and Obstetric Investigation, 77, 150-155. https://doi.org/10.1159/000358831
[47]
Farrow, K., Lakshminrusimha, S., Reda, W., Wedgwood, S., Czech, L., Gugino, S., Davis, J., Russell, J. and Steinhorn, R. (2008) Superoxide Dismutase Restores eNOS Expression and Function in Resistance Pulmonary Arteries from Neonatal Lambs with Persistent Pulmonary Hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology, 295, L979-L987. https://doi.org/10.1152/ajplung.90238.2008
[48]
Eleuterio, N.M., Palei, A.C., Rangel Machado, J.S., Tanus-Santos, J.E., Cavalli, R.C. and Sandrim, V.C. (2013) Relationship between Adiponectin and Nitrite in Healthy and Preeclampsia Pregnancies. Clinica Chimica Acta, 423, 112-115. https://doi.org/10.1016/j.cca.2013.04.027
[49]
Sankaralingam, S., Xu, H. and Davidge, S.T. (2010) Arginase Contributes to Endothelial Cell Oxidative Stress in Response to Plasma from Women with Preeclampsia. Cardiovascular Research, 85, 194-203. https://doi.org/10.1093/cvr/cvp277
[50]
Alpoim, P.N., Godoi, L.C., Freitas, L.G., Gomes, K.B. and Dusse, L.M. (2013) Assessment of L-Arginine Asymmetric 1 Dimethyl (ADMA) in Early-Onset and Late-Onset (Severe) Preeclampsia. Nitric Oxide, 33, 81-82. https://doi.org/10.1016/j.niox.2013.07.006
[51]
Crane, M.S., Rossi, A.G. and Megson, I.L. (2005) A Potential Role for Extracellular Nitric Oxide Generation in cGMP-Independent Inhibition of Human Platelet Aggregation: Biochemical and Pharmacological Considerations. British Journal of Pharmacology, 144, 849-859. https://doi.org/10.1038/sj.bjp.0706110
[52]
Johal, T., Lees, C.C., Everett, T.R. and Wilkinson, I.B. (2014) The Nitric Oxide Pathway and Possible Therapeutic Options in Pre-Eclampsia. British Journal of Clinical Pharmacology, 78, 244-257. https://doi.org/10.1111/bcp.12301
[53]
Prior, R.L., Wu, X. and Schaich, K. (2005) Standardized Methods for the Determination of Antioxidant Capacity and Phenolics in Foods and Dietary Supplements. Journal of Agricultural and Food Chemistry, 53, 4290-4302. https://doi.org/10.1021/jf0502698
[54]
Suresh, D. and Annam, V. (2013) Lipid Peroxidation and Total Antioxidant Capacity in Health and Disease—Pathophysiology and Markers: An Overview. International Journal of Medical Science and Public Health, 2, 487-489.
[55]
Hasan, F. and Dina, H. (2014) Relationship between Lipid Per Oxidation, Lepton and Lipid Profile in Iraqi Women with Preeclampsia. Engineering and Technology Journals, 32, 225-237.
[56]
Buonocore, G., Perrone, S. and Tataranno, M.L. (2010) Oxygen Toxicity: Chemistry and Biology of Reactive Oxygen Species. Seminars in Fetal & Neonatal Medicine, 15, 186-190. https://doi.org/10.1016/j.siny.2010.04.003
[57]
Raijmakers, M., Steegers, E. and Peters, W. (2001) Glutatione S-Transferases and thiol Concentrations in Embryonic and Early Fetal Tissues. Human Reproduction, 16, 2445-2450. https://doi.org/10.1093/humrep/16.11.2445
[58]
Manisha, A., Roshan, K. and Sudeep, K. (2015) Study of Lipid Peroxidation and Antioxidant Status in Preeclampsia. Advances in Bioresearch, 6, 144-148.
